HomeLIPO • OTCMKTS
add
Lipella Pharmaceuticals Inc
Previous close
$0.31
Day range
$0.31 - $0.31
Year range
$0.28 - $7.31
Market cap
1.42M USD
Avg Volume
13.66K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 553.30K | 12.21% |
Net income | -1.25M | 13.19% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.27M | 12.69% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.86M | 37.09% |
Total assets | 2.35M | 8.78% |
Total liabilities | 862.22K | 22.97% |
Total equity | 1.49M | — |
Shares outstanding | 4.62M | — |
Price to book | 0.97 | — |
Return on assets | -104.96% | — |
Return on capital | -133.63% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -1.25M | 13.19% |
Cash from operations | -926.06K | -41.79% |
Cash from investing | — | — |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -926.06K | -653.77% |
Free cash flow | -469.66K | -290.82% |
About
Founded
2005
Headquarters
Website
Employees
5
